Quent Capital’s Regions Financial RF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
8,181
-420
-5% -$11.8K 0.02% 374
2026
Q1
$225K Sell
8,601
-209
-2% -$5.84K 0.02% 360
2025
Q4
$239K Sell
8,810
-56
-0.6% -$1.43K 0.02% 348
2025
Q3
$234K Buy
8,866
+43
+0.5% +$1.12K 0.02% 256
2025
Q2
$208K Buy
8,823
+132
+2% +$2.79K 0.02% 271
2025
Q1
$189K Sell
8,691
-31
-0.4% -$722 0.02% 269
2024
Q4
$205K Buy
8,722
+274
+3% +$6.77K 0.02% 255
2024
Q3
$197K Buy
8,448
+159
+2% +$3.48K 0.02% 339
2024
Q2
$166K Buy
8,289
+6
+0.1% +$116 0.02% 345
2024
Q1
$174K Buy
8,283
+309
+4% +$5.84K 0.02% 355
2023
Q4
$155K Buy
7,974
+409
+5% +$6.79K 0.02% 351
2023
Q3
$130K Buy
7,565
+191
+3% +$3.62K 0.02% 350
2023
Q2
$131K Buy
7,374
+4
+0.1% +$71 0.02% 363
2023
Q1
$137K Buy
7,370
+4
+0.1% +$87 0.02% 354
2022
Q4
$159K Sell
7,366
-74
-1% -$1.6K 0.03% 313
2022
Q3
$149K Buy
7,440
+242
+3% +$5.11K 0.03% 293
2022
Q2
$135K Buy
7,198
+473
+7% +$9.76K 0.03% 294
2022
Q1
$150K Buy
6,725
+2,152
+47% +$50.6K 0.03% 335
2021
Q4
$100K Buy
+4,573
New +$105K 0.02% 407

Other funds holding RF

Quent Capital's RF Position: Q2 2026 in Review

Quent Capital reduced its Regions Financial (RF) stake by 4.9% in Q2 2026, selling an estimated $11.8K and leaving 8,181 shares worth $247K. The position accounts for 0.02% of the portfolio, ranked #374.

Quent Capital first reported a position in RF in Q4 2021 and has held it in 19 quarters since. 1,107 funds tracked by Wall St. Rank hold RF as of Q2 2026.

  • Quent Capital held 8,181 shares of Regions Financial worth $247K as of Q2 2026.
  • Quent Capital sold 420 Regions Financial shares in Q2 2026, an estimated $11.8K.
  • Regions Financial made up 0.02% of Quent Capital's portfolio in Q2 2026, its #374 holding.
  • Quent Capital first reported a position in Regions Financial in Q4 2021 and has held it in 19 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Regions Financial as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.